Bibliothèque de L'IMIST/CNRST

Electronic reproduction. Amsterdam : Elsevier Science and Technology, 2012. Mode of access: World Wide Web. System requirements: Web browser. Title from title screen (viewed on Apr. 16, 2012). Access may be restricted to users at subscribing institutions.

This is the third volume in the series based on a popular and well-received set of articles published in Optician magazine, and thoroughly updated to incorporate the latest drug information. It is comprehensive in its coverage of all issues relating to ocular therapeutics -- from record keeping for patient medications through to the basic pharmacology of drug delivery to the eye; systemic medications and drugs with their indications and contraindications for use.

An introduction: The issues surrounding the future expansion of the optometrists' role in ocular therapeutics in the UK; Legislation, legal aspects of medicine use and medicine types; Anatomy, neurophysiology and neuropharmacology of the eye; Neuropharmacology of the central and autonomic nervous system; Ophthalmic pharmaceuticals, their formulation and use; Medication-related adverse drug reactions (ADRs) and the anterior eye tissues; Vasodilation and inflammation of the anterior surface and its management; Medication-related adverse drug reactions (ADRs) - extra and intraocular muscles; Anti-infective drugs for ophthalmic use in primary eye care; Ophthalmic corticosteroids: management of the ocular inflammatory response; Systemic medications, intraocular pressure and the medical management of open-angle glaucoma; Appendix - UK-marketed pharmaceuticals relevant to management of ocular diseases.

Includes bibliographical references and index.